247 related articles for article (PubMed ID: 28691928)
1. Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis.
Zang S; Li J; Yang H; Zeng H; Han W; Zhang J; Lee M; Moczygemba M; Isgandarova S; Yang Y; Zhou Y; Rao A; You MJ; Sun D; Huang Y
J Clin Invest; 2017 Aug; 127(8):2998-3012. PubMed ID: 28691928
[TBL] [Abstract][Full Text] [Related]
2. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y; Sakata S; Kamada Y; Nakamoto-Matsubara R; Tran NB; Izutsu K; Sato Y; Ohta Y; Furuta J; Shimizu S; Komeno T; Sato Y; Ito T; Noguchi M; Noguchi E; Sanada M; Chiba K; Tanaka H; Suzukawa K; Nanmoku T; Hasegawa Y; Nureki O; Miyano S; Nakamura N; Takeuchi K; Ogawa S; Chiba S
Nat Genet; 2014 Feb; 46(2):171-5. PubMed ID: 24413737
[TBL] [Abstract][Full Text] [Related]
3. A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
Fernandez-Pol S; Ma L; Joshi RP; Arber DA
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):416-422. PubMed ID: 29629950
[TBL] [Abstract][Full Text] [Related]
4. RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis.
Cortes JR; Ambesi-Impiombato A; Couronné L; Quinn SA; Kim CS; da Silva Almeida AC; West Z; Belver L; Martin MS; Scourzic L; Bhagat G; Bernard OA; Ferrando AA; Palomero T
Cancer Cell; 2018 Feb; 33(2):259-273.e7. PubMed ID: 29398449
[TBL] [Abstract][Full Text] [Related]
5. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.
Nguyen PN; Tran NTB; Nguyen TPX; Ngo TNM; Lai DV; Deel CD; Hassell LA; Vuong HG
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):431-438. PubMed ID: 33849798
[TBL] [Abstract][Full Text] [Related]
7. Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.
Wang M; Zhang S; Chuang SS; Ashton-Key M; Ochoa E; Bolli N; Vassiliou G; Gao Z; Du MQ
Oncotarget; 2017 Mar; 8(11):17763-17770. PubMed ID: 28148900
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma.
Nguyen TB; Sakata-Yanagimoto M; Fujisawa M; Nuhat ST; Miyoshi H; Nannya Y; Hashimoto K; Fukumoto K; Bernard OA; Kiyoki Y; Ishitsuka K; Momose H; Sukegawa S; Shinagawa A; Suyama T; Sato Y; Nishikii H; Obara N; Kusakabe M; Yanagimoto S; Ogawa S; Ohshima K; Chiba S
Cancer Res; 2020 May; 80(9):1875-1884. PubMed ID: 32107212
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.
Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS
Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366
[TBL] [Abstract][Full Text] [Related]
10. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
[TBL] [Abstract][Full Text] [Related]
11. Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma.
Fukumoto K; Nguyen TB; Chiba S; Sakata-Yanagimoto M
Cancer Sci; 2018 Mar; 109(3):490-496. PubMed ID: 28889481
[TBL] [Abstract][Full Text] [Related]
12. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
[TBL] [Abstract][Full Text] [Related]
13. The curious origins of angioimmunoblastic T-cell lymphoma.
Cortés JR; Palomero T
Curr Opin Hematol; 2016 Jul; 23(4):434-43. PubMed ID: 27177312
[TBL] [Abstract][Full Text] [Related]
14. Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma.
Sakata-Yanagimoto M; Nakamoto-Matsubara R; Komori D; Nguyen TB; Hattori K; Nanmoku T; Kato T; Kurita N; Yokoyama Y; Obara N; Hasegawa Y; Shinagawa A; Chiba S
Ann Hematol; 2017 Sep; 96(9):1471-1475. PubMed ID: 28634614
[TBL] [Abstract][Full Text] [Related]
15. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.
Wang C; McKeithan TW; Gong Q; Zhang W; Bouska A; Rosenwald A; Gascoyne RD; Wu X; Wang J; Muhammad Z; Jiang B; Rohr J; Cannon A; Steidl C; Fu K; Li Y; Hung S; Weisenburger DD; Greiner TC; Smith L; Ott G; Rogan EG; Staudt LM; Vose J; Iqbal J; Chan WC
Blood; 2015 Oct; 126(15):1741-52. PubMed ID: 26268241
[TBL] [Abstract][Full Text] [Related]
16. TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.
Schwartz FH; Cai Q; Fellmann E; Hartmann S; Mäyränpää MI; Karjalainen-Lindsberg ML; Sundström C; Scholtysik R; Hansmann ML; Küppers R
J Pathol; 2017 Jun; 242(2):129-133. PubMed ID: 28337768
[TBL] [Abstract][Full Text] [Related]
17. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
Lee PH; Weng SW; Liu TT; You HL; Liao CK; Wang MC; Huang WT
Exp Mol Pathol; 2019 Oct; 110():104294. PubMed ID: 31394087
[TBL] [Abstract][Full Text] [Related]
18. Multistep tumorigenesis in peripheral T cell lymphoma.
Sakata-Yanagimoto M
Int J Hematol; 2015 Nov; 102(5):523-7. PubMed ID: 25628103
[TBL] [Abstract][Full Text] [Related]
19. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.
Yoo HY; Sung MK; Lee SH; Kim S; Lee H; Park S; Kim SC; Lee B; Rho K; Lee JE; Cho KH; Kim W; Ju H; Kim J; Kim SJ; Kim WS; Lee S; Ko YH
Nat Genet; 2014 Apr; 46(4):371-5. PubMed ID: 24584070
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment.
Tari G; Lemonnier F; Morschhauser F
Curr Opin Oncol; 2021 Sep; 33(5):400-405. PubMed ID: 34230442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
